Oncology & Specialty

Specialty and oncology medications.

928 products in catalog

Fotivda (Tivozanib)

1.34 mg/1 · Capsule

AVEO Pharmaceuticals, Inc.

Available to Source

Fotivda (Tivozanib)

.89 mg/1 · Capsule

AVEO Pharmaceuticals, Inc.

Available to Source

Xeljanz (Tofacitinib)

11 mg/1 · Extended-Release Tablet

U.S. Pharmaceuticals

Available to Source

Xeljanz (Tofacitinib)

1 mg/mL · Solution

U.S. Pharmaceuticals

Available to Source

Xeljanz (Tofacitinib)

11 mg/1 · Tablet Film Coated Extended Release

Pfizer Laboratories Div Pfizer Inc

Available to Source

Xeljanz (Tofacitinib)

22 mg/1 · Extended-Release Tablet

U.S. Pharmaceuticals

Available to Source

Xeljanz (Tofacitinib)

22 mg/1 · Tablet Film Coated Extended Release

Pfizer Laboratories Div Pfizer Inc

Available to Source

Xeljanz (Tofacitinib)

5 mg/1 · Film-Coated Tablet

Pfizer Laboratories Div Pfizer Inc

Available to Source

Xeljanz (Tofacitinib)

10 mg/1 · Film-Coated Tablet

Pfizer Laboratories Div Pfizer Inc

Available to Source

Xeljanz (Tofacitinib)

1 mg/mL · Solution

Pfizer Laboratories Div Pfizer Inc

Available to Source

Xeljanz (Tofacitinib)

5 mg/1 · Film-Coated Tablet

U.S. Pharmaceuticals

Available to Source

Xeljanz (Tofacitinib)

10 mg/1 · Film-Coated Tablet

U.S. Pharmaceuticals

Available to Source

Ojemda (Tovorafenib)

100 mg/1 · Film-Coated Tablet

Day One Biopharmaceuticals, Inc.

Available to Source

Mekinist (Trametinib)

.5 mg/1 · Film-Coated Tablet

Novartis Pharmaceuticals Corporation

Available to Source

Mekinist (Trametinib)

.05 mg/mL · Powder for Solution

Novartis Pharmaceuticals Corporation

Available to Source

Mekinist (Trametinib)

2 mg/1 · Film-Coated Tablet

Novartis Pharmaceuticals Corporation

Available to Source

Cosela (Trilaciclib)

300 mg/20mL · Lyophilized Injection Powder

Pharmacosmos Therapeutics Inc.

Available to Source

Tukysa (Tucatinib)

50 mg/1 · Tablet

Available to Source

Tukysa (Tucatinib)

150 mg/1 · Tablet

Available to Source

Rinvoq (Upadacitinib)

45 mg/1 · Extended-Release Tablet

Available to Source

Rinvoq (Upadacitinib)

30 mg/1 · Extended-Release Tablet

Available to Source

Rinvoq (Upadacitinib)

1 mg/mL · Solution

Available to Source

Rinvoq (Upadacitinib)

15 mg/1 · Extended-Release Tablet

Available to Source

Vafseo (Vadadustat)

150 mg/1 · Film-Coated Tablet

Akebia Therapeutics, Inc.

Available to Source